Sign Up to like & get recommendations! 1
Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.5839
Abstract: The changes in prognostic factors and clinicopathological characteristics of residual disease following neoadjuvant therapy (NAT) for breast cancer are important references for postoperative adjuvant therapy. The analyses of the relationship between the clinicopathological characteristics of… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27103
Abstract: The aim of this study was to analyze factors associated with pathologic complete response (pCR) following neoadjuvant chemoradiation (NCRT) and esophagectomy for carcinoma of the esophagus (EC) and gastroesophageal junction (GEJ). read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Surgery Today"
DOI: 10.1007/s00595-021-02397-0
Abstract: The purpose of this study was to clarify the clinical features and outcomes of patients with recurrence after esophagectomy following neoadjuvant chemotherapy (NAC) related to the timing of recurrence. We reviewed 240 consecutive patients who… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-020-05563-z
Abstract: Purpose Women with residual invasive breast cancer at the primary site or axillary lymph nodes following neoadjuvant chemotherapy have a high risk of recurrence. Eribulin improves survival in patients with metastatic breast cancer who progress… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Clinical breast cancer"
DOI: 10.1016/j.clbc.2021.03.011
Abstract: BACKGROUND The breast-conserving surgery (BCS) rate for patients with breast cancer in China is much lower than that in Europe and the United States. This study aimed to identify factors affecting the choice of surgical… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Seminars in thoracic and cardiovascular surgery"
DOI: 10.1053/j.semtcvs.2021.01.002
Abstract: OBJECTIVE We evaluated the feasibility of video-assisted thoracoscopic surgery (VATS) following neoadjuvant concurrent chemoradiotherapy (nCCRT) for N2 non-small cell lung cancer (NSCLC). METHODS We retrospectively reviewed patients with clinical N2 NSCLC who underwent lobectomy and… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Acta Oncologica"
DOI: 10.1080/0284186x.2019.1566775
Abstract: Abstract Purpose: We evaluate the effect of an exercised prehabilitation programme on tumour response in rectal cancer patients following neoadjuvant chemoradiotherapy (NACRT). Patients and Methods: Rectal cancer patients with (MRI-defined) threatened resection margins who completed… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Annals of Surgery"
DOI: 10.1097/sla.0000000000005619
Abstract: Objective: To compare overall (OS) and recurrence-free survival (RFS) in esophageal adenocarcinoma patients with a pathologically complete response (pCR) following neoadjuvant chemotherapy (nCT) or neoadjuvant chemoradiotherapy (nCRT). Background: In the absence of survival differences in… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Colorectal Disease"
DOI: 10.1111/codi.15583
Abstract: The aim of this work was to evaluate whether normalized carcinoembryonic antigen (CEA) following neoadjuvant chemoradiation predicts the prognosis following curative resection in locally advanced rectal cancer. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.01169
Abstract: Purpose: This study aimed to prospectively evaluate the early effects of radiation on cardiac structure and function following neoadjuvant chemoradiation for distal esophageal cancer. Methods and Materials: Patients with non-metastatic esophageal cancer who were suitable… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Current Oncology"
DOI: 10.3390/curroncol29080458
Abstract: Breast cancer continues to be the most diagnosed cancer among women worldwide. Neoadjuvant chemotherapy is the standard of care for breast cancer patients with locally advanced disease and patients with poor pathological features, such as… read more here.